Volver al feed
FinanzasMarketWatch.com - Top StoriesJaimy Lee

Contenido en inglés

Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market

Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market

En resumen

The Danish company Novo Nordisk says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

Fuente primaria
Leer artículo original
Publicado
Tema
Finanzas

The Danish company Novo Nordisk says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

Este resumen proviene de MarketWatch.com - Top Stories. Lee el artículo completo en la fuente original.

Referencias